Amylyx Pharmaceuticals Inc (AMLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -101,915 | -47,848 | -87,931 | -59,587 | -36,445 |
| Depreciation Amortization | 33 | 37 | 173 | 53 | 20 |
| Accounts payable and accrued liabilities | 3,755 | 5,020 | 670 | -716 | -872 |
| Other Working Capital | 4,687 | 2,785 | 4,595 | 5,706 | 4,264 |
| Other Operating Activity | 6,344 | -628 | 7,694 | 7,989 | 7,343 |
| Operating Cash Flow | $-87,096 | $-40,634 | $-74,799 | $-46,555 | $-25,690 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -93,402 | -98,969 | -46,053 | -49,053 | N/A |
| PPE Investments | -1,447 | -342 | -353 | -167 | -14 |
| Investing Cash Flow | $-94,849 | $-99,311 | $-46,406 | $-49,220 | $-14 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 26,159 | 26,159 | 26,159 |
| Debt Repayment | N/A | N/A | -263 | N/A | -263 |
| Common Stock Issued | 201,145 | 200,897 | 343 | 198 | 34 |
| Other Financing Activity | -1,518 | -442 | 132,267 | 133,214 | 1,990 |
| Financing Cash Flow | $199,627 | $200,455 | $158,506 | $159,571 | $27,920 |
| Exchange Rate Effect | -203 | -68 | 13 | 4 | 2 |
| Beginning Cash Position | 50,380 | 50,380 | 13,066 | 13,066 | 13,066 |
| End Cash Position | 67,859 | 110,822 | 50,380 | 76,866 | 15,284 |
| Net Cash Flow | $17,479 | $60,442 | $37,314 | $63,800 | $2,218 |
| Free Cash Flow | |||||
| Operating Cash Flow | -87,096 | -40,634 | -74,799 | -46,555 | -25,690 |
| Capital Expenditure | -1,447 | -342 | -353 | -167 | -14 |
| Free Cash Flow | -88,543 | -40,976 | -75,152 | -46,722 | -25,704 |